CHD Stock - Church & Dwight Co., Inc.
Unlock GoAI Insights for CHD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.11B | $5.87B | $5.38B | $5.19B | $4.90B |
| Gross Profit | $2.79B | $2.59B | $2.25B | $2.26B | $2.21B |
| Gross Margin | 45.7% | 44.1% | 41.9% | 43.6% | 45.2% |
| Operating Income | $807.10M | $1.06B | $597.80M | $1.08B | $1.03B |
| Net Income | $585.30M | $755.60M | $413.90M | $827.50M | $785.90M |
| Net Margin | 9.6% | 12.9% | 7.7% | 15.9% | 16.1% |
| EPS | $2.39 | $3.09 | $1.70 | $3.38 | $3.18 |
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 17th 2025 | Jefferies | Upgrade | Buy | $102 |
| December 17th 2025 | Citigroup | Upgrade | Neutral | $87 |
| July 14th 2025 | Rothschild & Co Redburn | Downgrade | Sell | $83 |
| June 2nd 2025 | RBC Capital Mkts | Upgrade | Outperform | $114 |
| May 6th 2025 | TD Cowen | Downgrade | Hold | $100 |
| April 15th 2025 | BofA Securities | Upgrade | Buy | $125 |
| September 24th 2024 | Piper Sandler | Initiation | Overweight | $120 |
| September 9th 2024 | Morgan Stanley | Downgrade | Equal Weight | $110 |
| July 23rd 2024 | TD Cowen | Initiation | Buy | $116 |
| June 24th 2024 | Exane BNP Paribas | Initiation | Neutral | $114 |
| March 1st 2024 | Goldman | Resumed | Buy | $110 |
| February 23rd 2024 | Argus | Upgrade | Buy | $115 |
| December 15th 2023 | BofA Securities | Upgrade | Neutral | $100← $85 |
| December 13th 2023 | Citigroup | Downgrade | Sell | $90 |
| November 13th 2023 | Jefferies | Initiation | Hold | $99 |
Earnings History & Surprises
CHDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Jan 30, 2026 | $0.85 | — | — | — |
Q4 2025 | Oct 31, 2025 | $0.74 | $0.81 | +10.1% | ✓ BEAT |
Q3 2025 | Aug 1, 2025 | $0.86 | $0.94 | +9.7% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $0.90 | $0.91 | +1.6% | ✓ BEAT |
Q1 2025 | Jan 31, 2025 | $0.77 | $0.77 | 0.0% | = MET |
Q4 2024 | Nov 1, 2024 | $0.68 | $0.79 | +15.8% | ✓ BEAT |
Q3 2024 | Aug 2, 2024 | $0.84 | $0.93 | +10.7% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.87 | $0.96 | +10.3% | ✓ BEAT |
Q1 2024 | Feb 2, 2024 | $0.65 | $0.65 | 0.0% | = MET |
Q4 2023 | Nov 3, 2023 | $0.69 | $0.74 | +7.2% | ✓ BEAT |
Q3 2023 | Jul 28, 2023 | $0.79 | $0.89 | +12.7% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.78 | $0.82 | +5.1% | ✓ BEAT |
Q1 2023 | Feb 3, 2023 | $0.60 | $0.62 | +3.3% | ✓ BEAT |
Q4 2022 | Oct 28, 2022 | $0.65 | $0.76 | +16.9% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | $0.72 | $0.76 | +5.6% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $0.77 | $0.83 | +7.8% | ✓ BEAT |
Q1 2022 | Jan 28, 2022 | $0.60 | $0.64 | +6.7% | ✓ BEAT |
Q4 2021 | Oct 29, 2021 | $0.71 | $0.80 | +12.7% | ✓ BEAT |
Q3 2021 | Jul 30, 2021 | $0.70 | $0.76 | +8.6% | ✓ BEAT |
Latest News
Citigroup Upgrades Church & Dwight Co to Neutral, Raises Price Target to $87
➖ NeutralJefferies Upgrades Church & Dwight Co to Buy, Raises Price Target to $102
📈 PositiveDeutsche Bank Maintains Buy on Church & Dwight Co, Lowers Price Target to $100
➖ NeutralChurch & Dwight Agrees To Sell VitaFusion And L'il Critters Brands To Piping Rock Health Products; Terms Not Disclosed
➖ NeutralArgus Research Maintains Buy on Church & Dwight Co, Lowers Price Target to $102
📈 PositiveBarclays Maintains Underweight on Church & Dwight Co, Lowers Price Target to $82
📉 NegativeChurch & Dwight shares are trading higher after the company reported better-than-expected Q3 financial result and issued FY25 adjusted EPS guidance above estimates.
📈 PositiveChurch & Dwight Co Sees Q4 Adj EPS $0.83 vs $0.90 Est
📉 NegativeChurch & Dwight Co Narrows FY2025 Adj EPS Guidance from $3.44-$3.51 to $3.49 vs $3.47 Est
➖ NeutralChurch & Dwight Co Q3 Adj. EPS $0.81 Beats $0.74 Estimate, Sales $1.585B Beat $1.536B Estimate
📈 PositiveOppenheimer Maintains Outperform on Church & Dwight Co, Lowers Price Target to $100
➖ NeutralCitigroup Maintains Sell on Church & Dwight Co, Lowers Price Target to $85
📉 NegativeB of A Securities Maintains Buy on Church & Dwight Co, Lowers Price Target to $105
➖ NeutralUBS Maintains Neutral on Church & Dwight Co, Lowers Price Target to $98
➖ NeutralWells Fargo Maintains Overweight on Church & Dwight Co, Lowers Price Target to $100
➖ NeutralChurch & Dwight to acquire hand sanitizer brand for up to $880M
📈 PositiveChurch & Dwight cuts forecast amid macro uncertainty, tariff impact; posts tepid Q1
📉 NegativeFrequently Asked Questions about CHD
What is CHD's current stock price?
What is the analyst price target for CHD?
What sector is Church & Dwight Co., Inc. in?
What is CHD's market cap?
Does CHD pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to CHD for comparison